Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy

被引:73
作者
Mijatovic, Velja [1 ]
Veersema, Sebastiaan [2 ]
Emanuel, Mark Hans [3 ]
Schats, Roel
Hompes, Peter G. A.
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Reprod Med, NL-1081 HV Amsterdam, Netherlands
[2] St Antonius Hosp, Nieuwegein, Netherlands
[3] Spaarne Hosp, Hoofddorp, Netherlands
关键词
Essure hysteroscopic tubal occlusion; hydrosalpinges; IVF-ET; PREGNANCY RATES; SALPINGECTOMY; IVF; IMPLANTATION; INFERTILITY;
D O I
10.1016/j.fertnstert.2008.11.022
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To investigate the success rate of proximal tubal occlusion with Essure devices in subfertile women with hydrosalpinges, and to observe the results of subsequent treatment with IVF. Design: Prospective, single-arm, clinical study. Setting: University hospital and teaching hospital. Patient(s): Ten women with uni- or bilateral hydrosalpinges prior to IVF. In all patients laparoscopy was felt to be contraindicated. Intervention(s): Hysteroscopic placement of Essure devices in an office setting. Main Outcome Measure(s): Placement rate, successful proximal tubal occlusion, and pregnancy rate after IVF. Result(s): All patients had successful placement of the Essure devices without any complications. Proximal tubal occlusion was confirmed by hysterosalpingography in 9 out of 10 patients. A 40% ongoing pregnancy rate was achieved with 20% life births after one IVF cycle and/or frozen embryo transfer. Conclusion(s): Proximal occlusion of hydrosalpinges with Essure devices before IVF is a successful treatment for patients with a contraindication for salpingectomy. (Fertil Steril (R) 2010 93:1338-42. (C) 2010 by American Society for Reproductive Medicine.)
引用
收藏
页码:1338 / 1342
页数:5
相关论文
共 19 条
  • [1] Andersen AN, 1996, HUM REPROD, V11, P2081
  • [2] [Anonymous], 2004, COCHRANE DB SYST REV
  • [3] Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies
    Camus, E
    Poncelet, C
    Goffinet, F
    Wainer, B
    Merlet, F
    Nisand, I
    Philippe, HJ
    [J]. HUMAN REPRODUCTION, 1999, 14 (05) : 1243 - 1249
  • [4] Only hydrosalpinges visible on ultrasound are associated with reduced implantation and pregnancy rates after in-vitro fertilization
    de Wit, W
    Gowrising, CJ
    Kuik, DJ
    Lens, JW
    Schats, R
    [J]. HUMAN REPRODUCTION, 1998, 13 (06) : 1696 - 1701
  • [5] Does previous salpingectomy improve implantation and pregnancy rates in patients with severe tubal factor infertility who are undergoing in vitro fertilization?: A pilot prospective randomized study
    Déchaud, H
    Daurès, JP
    Arnal, F
    Humeau, C
    Hédon, B
    [J]. FERTILITY AND STERILITY, 1998, 69 (06) : 1020 - 1025
  • [6] Utilization of the Essure® micro-insert for the treatment of hydrosalpinx prior to in vitro fertilization
    Galen, D. I.
    [J]. FERTILITY AND STERILITY, 2007, 88 : S16 - S16
  • [7] Goldstein DB., 1998, FERTIL STERIL, V70, pS320
  • [8] Essure treatment of hydrosalpinges
    Hitkari, Jason A.
    Singh, Sukhbir S.
    Shapiro, Heather M.
    Leyland, Nicholas
    [J]. FERTILITY AND STERILITY, 2007, 88 (06) : 1663 - 1666
  • [9] Hysteroscopic sterilization using a micro-insert device: results of a multicentre phase II study
    Kerin, JF
    Cooper, JM
    Price, T
    Van Herendael, BJ
    Cayuela-Font, E
    Cher, D
    Carignan, CS
    [J]. HUMAN REPRODUCTION, 2003, 18 (06) : 1223 - 1230
  • [10] Tissue encapsulation of the proximal Essure micro-insert from the uterine cavity following hysteroscopic sterilization
    Kerin, John F.
    Munday, David
    Ritossa, Martin
    Rosen, David
    [J]. JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2007, 14 (02) : 202 - 204